HOME >> MEDICINE >> NEWS
Millennium, Aventis Pharma form novel alliance

CAMBRIDGE, Mass. and FRANKFURT, Germany, June 23, 2000 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) and Aventis Pharma, the pharmaceutical company of Aventis S.A. (NYSE: AVE), and today announced that they have formed a unique alliance with the signing of agreements covering the joint development and commercialization of drugs for the treatment of inflammatory diseases; joint development of new drug discovery technologies; transfer of key elements of Millennium's technology platform to Aventis to enhance its existing capabilities; and purchase of an equity interest in Millennium by Aventis. This is the first biotechnology/pharmaceutical company alliance of its kind, which will result in Millennium and Aventis Pharma working collaboratively to identify drug targets and develop new drugs in the field of inflammation and jointly commercialize the resulting products in North America.

The foundation for this alliance is the establishment of four separate arrangements covering Inflammation, Technology Development, Technology Transfer and an Equity Investment. Under a Technology Transfer Agreement, Millennium will provide Aventis with rights to its drug discovery technologies in exchange for payments of up to $200 million over a five-year period. Under an Equity Investment Agreement, Aventis will also invest $250 million in Millennium's common stock. A $150 million stock purchase will be made at closing and two $50 million purchases will be made in 2001. The combination of the Technology Transfer and the Investment Agreements represent a total of up to $450 million in payments to and investments in Millennium by Aventis. Both the Inflammation and Technology Development Agreements call for joint funding by the two companies. The closing may be subject to expiration or early termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.

Millennium and Aventis Pharma Form Novel Alliance to Develop and Commerc
'"/>

Contact: Sally McCraven, Millennium Pharmaceuticals, Inc.
617-577-3548
Porter Novelli
22-Jun-2000


Page: 1 2 3 4 5 6

Related medicine news :

1. Aventis Pasteur ready to meet nations needs for tetanus and diphtheria vaccine
2. Aventis Pasteur donates approximately 75 to 90 million doses of smallpox vaccine to the U.S.
3. Aventis Pasteur statement on HVTN 501 decision
4. Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years
5. 2005 Pharmacology, Therapeutics, & Toxicology Research Award
6. Pharmacist review does not keep older people out of hospital
7. Pharmaceutical marketing tactics hold little sway with prescribing physicians
8. Pharmacists want role in drug importation, study shows
9. Eyetech Pharmaceuticals, Inc. announces macugen data on treating macular degeneration
10. 2004 Pharmacology/Therapeutics/Toxicology Award to Haas
11. Pharmacists play role in cholesterol control

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Millennium Aventis Pharma form novel alliance

(Date:6/19/2013)... June 19, 2013 PrettySkin4Less announces it ... skin serums by top skin care manufacturer EMINENCE ... concentrations of vitamins, minerals and active organic ingredients to ... so many other beauty products offer. For this reason ... up. , "I like products that do what ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Brain not ... DC, MS, explains why such seemingly minor brain problems ... concussions are vital red flags. They indicate the brain ... multiple sclerosis (MS), Alzheimer’s, Parkinson’s, stroke, and other neurological ... in June 2013 by Elephant Press is now available ...
(Date:6/19/2013)... Chrysler made news recently when it refused to accept the ... Jeep models in question are the 1993-2004 Jeep Grand Cherokee ... are vulnerable to fire and explosion in a crash. (1) ... have been alleged to catch fire or explode upon impact. ... rear-end crashes, which resulted in 44 deaths and the Liberty ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Citi Bike has come ... way for Dr. David Perna to know for sure how many ... he’s happy that they’ll have the option. In fact, he’s ... if it might also make it more convenient for them to ... is the Director of Complimentary Alternative Medicine at Back and Body ...
(Date:6/19/2013)... 2013 The Journal of Parasitology – ... computer software, it creates questions of ethics. For scientific ... an already published case shows, scientific publications need clear ... The Journal of Parasitology features a commentary ... 2004 article published in the Journal of the New ...
Breaking Medicine News(10 mins):Health News:PrettySkin4Less Launches New Innovative Skin Serums with Active Organic Ingredients to World Wide Consumer Base 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 2Health News:Brain Not Working? Minor Symptoms Now Could Mean MS, Alzheimer's, or Parkinson's Later 3Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 2Health News:Zinda & Davis PLLC: Why the Chrysler Recall Refusal Matters And May Set a Dangerous Precedent 3Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 2Health News:New York City's Back and Body Medical Welcomes Citi Bike to Midtown Manhattan 3Health News:Altered Photo in Journal Article Illustrates the Need for Manipulation Guidelines 2
(Date:6/19/2013)... Mass. , June 19, 2013  Haemonetics ... several important developments in the pursuit of its ... http://photos.prnewswire.com/prnh/20120206/NE47232LOGO ) , Haemonetics ... ) for the future production of medical devices ... Massachusetts. Sanmina is a leading global provider of integrated ...
(Date:6/19/2013)... 2013 /PRNewswire-iReach/ -- Robert M. Bernstein, M.D., ... procedures and founder of Bernstein Medical – Center ... Doctors, issue of New York Magazine for the ... ) Dr. Bernstein earned his ... reputation as world-renowned hair restoration physician, through a ...
(Date:6/19/2013)... -- Dr. Davis Lee , CMIO for PIH ... the 2013 AMDIS Award, a prestigious recognition saluting excellence ... "On behalf of Allscripts, I,d like to congratulate ... continuous efforts to improve patient care and population health," ... Executive Officer of Allscripts. "We are committed to our ...
Breaking Medicine Technology:Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 2Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 3Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 4Allscripts Congratulates Dr. Davis Lee, Winner of the 2013 Association of Medical Directors of Information Systems (AMDIS) Award 5
Cached News: